Vassilakopoulos, T.P.; Liaskas, A.; Pereyra, P.; Panayiotidis, P.; Angelopoulou, M.K.; Gallamini, A.
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma. Int. J. Mol. Sci. 2023, 24, 13187.
https://doi.org/10.3390/ijms241713187
AMA Style
Vassilakopoulos TP, Liaskas A, Pereyra P, Panayiotidis P, Angelopoulou MK, Gallamini A.
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma. International Journal of Molecular Sciences. 2023; 24(17):13187.
https://doi.org/10.3390/ijms241713187
Chicago/Turabian Style
Vassilakopoulos, Theodoros P., Athanasios Liaskas, Patricio Pereyra, Panayiotis Panayiotidis, Maria K. Angelopoulou, and Andrea Gallamini.
2023. "Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma" International Journal of Molecular Sciences 24, no. 17: 13187.
https://doi.org/10.3390/ijms241713187
APA Style
Vassilakopoulos, T. P., Liaskas, A., Pereyra, P., Panayiotidis, P., Angelopoulou, M. K., & Gallamini, A.
(2023). Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma. International Journal of Molecular Sciences, 24(17), 13187.
https://doi.org/10.3390/ijms241713187
